PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
 
AAPS PharmSciTech. 2007 June; 8(2): E86–E93.
Published online 2007 May 18. doi:  10.1208/pt0802038
PMCID: PMC2750377

Stability study of stavudine-loaded O-palmitoyl-anchored carbohydrate-coated liposomes

Abstract

The purpose of this study was to evaluate the physicochemical stability of carbohydrate-anchored liposomes. In the present study, carbohydrate (galactose, fucose, and mannose) was palmitoylated and anchored on the surface of positively charged liposomes (PL). The stabilities of plain neutral liposomes (NL), PL, and O-palmitoyl carbohydrate-anchored liposomes were determined. The effects of storage conditions (4°C±2°C, 25°C±2°C/60%±5% relative humidity [RH], or 40°C±2°C/75%±5% RH for a period of 10, 20, and 30 days) were observed on the vesicle size, shape, zeta potential, drug content, and in vitro ligand agglutination assay by keeping the liposomal formulations in sealed ambercolored vials (10-mL capacity) after flushing with nitrogen. The stability of liposomal formulations was found to be temperature dependent. All the liposomal formulations were found to be stable at 4°C±2°C up to 1 month. Storage at 25°C±2°C/60%±5% RH and 40°C±2°C/75%±5% RH adversely affected uncoated liposomal formulations. Carbohydrate coating of the liposomes could enhance the stability of liposomes at 25°C±2°C/60%±5% RH and 40°C±2°C/75%±5% RH.

Keywords: Carbohydrate-coated liposomes, stavudine, stability, oxidation index, thiobarbituric acid-reactive species

Full Text

The Full Text of this article is available as a PDF (472K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Satish PR, Surolia A. Preparation and characterization of glycolipid bearing multilamellar and unilamellar liposomes. In: Basu SC, Basu M, editors. Liposome Methods and Protocols. Totowa, NJ: Humana Press; 2002. pp. 193–202. [PubMed]
2. Allen TM. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev. 1994;13:285–309. doi: 10.1016/0169-409X(94)90016-7. [Cross Ref]
3. Mehvar R. Recent trends in the use of polysaccharides for improved delivery of therapeutic agents: pharmacokinetic and pharmacodynamic perspectives. Curr Pharm Biotechnol. 2003;4:283–302. doi: 10.2174/1389201033489685. [PubMed] [Cross Ref]
4. Letourneur D, Parisel C, Prigent-Richard S, Cansell M. Interactions of functionalized dextran-coated liposomes with vascular smooth muscle cells. J Control Rel. 2000;65:83–91. doi: 10.1016/S0168-3659(99)00240-0. [PubMed] [Cross Ref]
5. Sato T, Sunamoto J. Recent aspects in the use of liposomes in biotechnology and medicine. Prog Lipid Res. 1992;31:345–372. doi: 10.1016/0163-7827(92)90001-Y. [PubMed] [Cross Ref]
6. Moellerfeld J, Prass W, Ringsdorf H, Hamazaki H, Sunamoto J. Improved stability of black lipid membranes by coating with polysaccharide derivatives bearing hydrophobic anchor groups. Biochim Biophys Acta. 1986;857:265–270. doi: 10.1016/0005-2736(86)90355-X. [Cross Ref]
7. Yohannes G, Pystynen KH, Riekkola M, Wiedmer SK. Stability of phospholipid vesicles studied by asymmetrical flow field-flow fractionation and capillary electrophoresis. Anal Chim Acta. 2006;560:50–56. doi: 10.1016/j.aca.2005.12.042. [Cross Ref]
8. Sharma A, Sharma US. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154:123–140. doi: 10.1016/S0378-5173(97)00135-X. [Cross Ref]
9. Senior J, Gregoriadis G. Methodology in assessing liposomal stability in the presence of blood: clearance from the circulation of injected animals and uptake by tissues. In: Gregoriadis G, editor. Liposome Technology. Boca Raton, FL: CRC Press; 1984. pp. 264–282.
10. Ruozi B, Tosi G, Forni F, Fresta M, Vandelli MA. Atomic force microscopy and photon correlation spectroscopy: two techniques for rapid characterization of liposomes. Eur J Pharm Sci. 2005;25:81–89. doi: 10.1016/j.ejps.2005.01.020. [PubMed] [Cross Ref]
11. Garg M, Asthana A, Agashe HB, Agrawal GP, Jain NK. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics. J Pharm Pharmacol. 2006;58:605–616. doi: 10.1211/jpp.58.5.0005. [PubMed] [Cross Ref]
12. Zhang JA, Anyarambhatla G, Ma L, et al. Development and characterization of a novel Cremophor EL free liposome-based paclitaxel (LEP-ETU) formulation. Eur J Pharm Biophar. 2005;59:177–187. doi: 10.1016/j.ejpb.2004.06.009. [PubMed] [Cross Ref]
13. Fry DW, White JC, Goldman ID. Rapid separation of low molecular weight solutes from liposomes without dilution. Anal Biochem. 1978;90:809–815. doi: 10.1016/0003-2697(78)90172-0. [PubMed] [Cross Ref]
14. New RRC. Introduction and preparation of liposomes. In: New RRC, editor. Liposomes: A Practical Approach. Oxford, UK: Oxford University Press; 1990. pp. 1–104.
15. Haensler J, Schuber F. Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages. Biochim Biophys Acta. 1988;946:95–105. doi: 10.1016/0005-2736(88)90461-0. [PubMed] [Cross Ref]
16. Copland MJ, Baird MA, Rades T, et al. Liposomal delivery of antigen to human dendritic cells. Vaccine. 2003;21:883–890. doi: 10.1016/S0264-410X(02)00536-4. [PubMed] [Cross Ref]
17. Umamaheshwari RB, Jain NK. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target. 2003;11:415–424. doi: 10.1080/10611860310001647771. [PubMed] [Cross Ref]
18. Buege JA, Aust SD. Microsomal lipid peroxidation. In: Fleischer S, Packer L, editors. Methods in Enzymology Biomembranes. Part C: Biological Oxidations. London, UK: Academic Press; 1978. pp. 302–310.
19. Genot C, Metro B, Viau M, Bouchet B. Characterisation and stability during storage of liposomes made of muscle phospholipids. Lebensm Wiss Technol. 1999;32:167–174. doi: 10.1006/fstl.1998.0525. [Cross Ref]
20. Mcevoy GK, Miller J, Snow EK. Stability of liposomes: Cytarabine (Systemic) In: Mcevoy GK, Miller J, Snow EK, editors. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacist; 2004. pp. 522–660.
21. Hincha DK. Effects of calcium-induced aggregation on the physical stability of liposomes containing plant glycolipids. Biochim Biophys Acta. 2003;1611:180–186. doi: 10.1016/S0005-2736(03)00053-1. [PubMed] [Cross Ref]
22. Cimato AN, Piehl LL, Facorro GB, Torti HB, Hager AA. Antioxidant effects of water- and lipid-soluble nitroxide radicals in liposomes. Free Radic Biol Med. 2004;37:2042–2051. doi: 10.1016/j.freeradbiomed.2004.09.020. [PubMed] [Cross Ref]
23. Zhu J, Yan F, Guo Z, Marchant RE. Surface modification of liposomes by saccharides: vesicle size and stability of lactosyl liposomes studied by photon correlation spectroscopy. J Colloid Interface Sci. 2005;289:542–550. doi: 10.1016/j.jcis.2005.03.088. [PubMed] [Cross Ref]
24. Gabriels M, Plaizier-Vercammen J. Physical and chemical evaluation of liposomes, containing artesunate. J. Pharm Biomed Anal. 2003;31:655–667. doi: 10.1016/S0731-7085(02)00678-7. [PubMed] [Cross Ref]
25. Gabriels M, Cirunay J, Alafandy M, et al. Determination of hydroperoxides in liposomes by the modified IDF and the modified tiron methods. J AOAC Int. 2000;83:589–596. [PubMed]
26. Vossen RCRM, van Dam-Mieras MCE, Hornstra G, Zwaal RFA. Continuous monitoring of lipid peroxidation by measuring conjugated diene formation in an aqueous liposome suspension. Lipids. 1993;28:857–861. doi: 10.1007/BF02536243. [PubMed] [Cross Ref]
27. Klein RA. The detection of oxidation in liposome preparations. Biochim Biophys Acta. 1970;210:486–489. [PubMed]
28. Hager A, De Paoli T, Ihlo J, Farch H, Pooles C. Stability study of lecithin liposomes during storage using ESR. Spectrochim Acta [A] 1993;49:1999–2005.
29. Lasic DD. Liposomes: From Physics to Applications. Amsterdam, The Netherlands: Elsevier; 1993. pp. 108–201.
30. Bast A, Goris RJA. Oxidative stress: biochemistry and human disease. PharmWeek Sci. 1989;11:199–206. [PubMed]
31. Janero DR. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Rad Biol Med. 1990;9:515–540. doi: 10.1016/0891-5849(90)90131-2. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists